Familial Amyloid Polyneuropathy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Familial Amyloid Polyneuropathy
Familial Amyloid Polyneuropathy (FAP) is a rare, inherited condition where abnormal proteins build up, damaging nerves and organs. Managing FAP often requires specific, expensive medications. TheDrugClub helps make these vital treatments more accessible and affordable, ensuring you can focus on your health without the added burden of high prescription costs.
Familial Amyloid Polyneuropathy (FAP), also known as transthyretin amyloidosis (ATTRv amyloidosis), is a progressive and often debilitating genetic disorder. It's caused by a mutation in the transthyretin (TTR) gene, which leads to the production of unstable TTR proteins. These misfolded proteins accumulate as amyloid deposits in various tissues and organs throughout the body, most notably in the peripheral and autonomic nervous systems, but also affecting the heart, kidneys, eyes, and gastrointestinal tract.
The symptoms of FAP can vary widely depending on which organs are affected. Patients often experience sensory and motor neuropathy, leading to numbness, tingling, pain, and weakness, particularly in the limbs. Autonomic neuropathy can cause issues with digestion, blood pressure regulation, and bladder control. As the disease progresses, heart problems like cardiomyopathy, kidney dysfunction, and vision impairment can also emerge, significantly impacting quality of life.
While FAP is a serious condition, advancements in medical research have led to effective treatments that can slow its progression and manage symptoms. Common medications include TTR stabilizers, such as tafamidis, which help prevent the misfolding of TTR proteins. Another class of treatments involves gene silencers, like patisiran, inotersen, and vutrisiran, which reduce the production of the abnormal TTR protein. For some specific types of FAP, a liver transplant might be considered. These medications, while life-changing, are often specialty drugs
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.